SCHEMBL5599432

SCHEMBL5599432

CCCCCCCCCCCCc1ccc(-c2ccccc2-c2ccccc2)cc1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSD11B1 P28845 3/20 0.61
RARB P10826 7/20 0.56
ALDH1A1 P00352 2/20 0.56
MEN1 O00255 1/20 0.56
RARA P10276 1/20 0.56
MAPT P10636 1/20 0.56
MTOR P42345 1/20 0.56
KMT2A Q03164 1/20 0.56
HTR2A P28223 2/20 0.54
ESR1 P03372 2/20 0.53
ADRA2A P08913 2/20 0.53
ADORA3 P0DMS8 2/20 0.53
TACR2 P21452 2/20 0.53
SLC6A2 P23975 2/20 0.53
SLC6A4 P31645 2/20 0.53
SLC6A3 Q01959 2/20 0.53
HSD17B10 Q99714 2/20 0.53
KDM4E B2RXH2 1/20 0.53
LMNA P02545 1/20 0.53
SHBG P04278 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL35867 1.00 HSD11B1 (0.61) HSD11B1RARBALDH1A1MEN1RARA
Hydrogen Sulfide SCHEMBL27798487 0.98 HSD11B1 (0.59) HSD11B1RARBALDH1A1MEN1RARA
Phosphine SCHEMBL27456116 0.98 HSD11B1 (0.59) HSD11B1RARBALDH1A1MEN1RARA
Hydrogen Sulfide SCHEMBL28025844 0.98 HSD11B1 (0.59) HSD11B1RARBALDH1A1MEN1RARA
Phosphine SCHEMBL27545611 0.98 HSD11B1 (0.59) HSD11B1RARBALDH1A1MEN1RARA
SCHEMBL29939361 0.98 HSD11B1 (0.63) HSD11B1RARBALDH1A1MEN1RARA
SCHEMBL11512580 0.92 HSD11B1 (0.62) HSD11B1RARBALDH1A1MEN1RARA
SCHEMBL9158137 0.90 HSD11B1 (0.67) HSD11B1RARBALDH1A1MEN1RARA
SCHEMBL4598933 0.90 HSD11B1 (0.67) HSD11B1RARBALDH1A1MEN1RARA
SCHEMBL1533772 0.90 HSD11B1 (0.67) HSD11B1RARBALDH1A1MEN1RARA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1312605-B1 Method for producing biaryl compounds SUMITOMO CHEMICAL CO (JP) 2007-04-25 EP disclosed
US-7122711-B2 Method for producing biaryl compound SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2006-10-17 US disclosed
US-20030158419-A1 Method for producing biaryl compound SUMITOMO CHEMICAL COMPANY, LIMITED 2003-08-21 US disclosed
EP-1312605-A1 Method for producing biaryl compounds SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2003-05-21 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030158419-A1 Method for producing biaryl compound B2M, BMI1, CYP2W1 HSD11B1 767/4885RARB 998/4885ALDH1A1 1565/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.